The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrifast Regulatory News (TRI)

Share Price Information for Trifast (TRI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 74.60
Bid: 74.00
Ask: 74.60
Change: 3.20 (4.48%)
Spread: 0.60 (0.811%)
Open: 77.00
High: 77.00
Low: 74.60
Prev. Close: 71.40
TRI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update & Notice of Annual results

5 May 2022 07:00

RNS Number : 3702K
Trifast PLC
05 May 2022
 

 

 

 

 

Trifast plc

(Trifast, or Group)

 

"Innovation today for a better tomorrow - Growing sustainably, together"

 

Trading Update & Notice of Full Year Results

 

London, Thursday, 5 May 2022: Trifast plc (LSE Main market premium listing: symbol: TRI), a leading international specialist in the design, engineering, manufacture, and distribution of high-quality industrial fastenings and Category 'C' components principally to major global assembly industries, issues the following unaudited Trading Update for the year ended 31 March 2022 (FY2022) ahead of the announcement of its Full Year results on 21 June 2022.

 

TRADING UPDATE

Strong trading continued in Q4, contributing to year-on-year organic revenue growth at constant exchange rate (CER) of c.15% for FY2022 (organic growth at CER of c.9% against FY2020). As a result, the Group expects to report an overall trading performance for FY2022, in line with the Board's expectations.

 

Driven by strong underlying demand, sales to distributors remained very high in the final quarter and our Hungarian operations saw robust growth in the energy, tech & infrastructure (ET&I) sector. Light vehicle sector volumes continue to experience high levels of volatility in demand due to ongoing supply chain disruption, particularly in Europe and the UK. Towards the end of Q4, we started to see this disruption move into the health & home sector, with temporary factory closures across several of our Global OEMs operating in Europe.

 

The Covid-19 lockdowns in Shanghai, have had a limited impact on FY2022 trading, however, we are currently unable to trade above a minimal level due to the restrictions in place. The impact on our wider Asia region has not been significant to date. Our North America region continues to go from strength to strength, with strong organic revenue growth at our Houston site, driven by light vehicle and ET&I sales, being further supplemented by a solid trading performance from TR Falcon. The Ukraine conflict has had a minimal direct impact on the business in Q4, with

 

We have successfully concluded most of our phase one price increase programme negotiations. Although further inflationary cost increases have held back a full margin recovery, we are pleased to report that in March 2022 we recorded gross margins much closer to historic levels. We expect price increase negotiations to be an ongoing part of doing business in the current macroeconomic environment. With this in mind, we are already reaching out to our customer base to discuss a prompt pass-on of relevant additional costs, including increased energy and broader macro costs.

 

Supply chain challenges remain and although lead times are now stabilising across most of the world, these continue to stand at high levels. Considering this challenging backdrop and given our strong financial position, the business has continued to invest in inventory levels in the second half to ensure reliability of supply. Net debt (before IFRS16) at the period end was c.£25m, with this expected to reduce and drive historically high cash generation rates, as the macroeconomic environment settles.

 

Our acquisition strategy continues at pace and a good pipeline of targets in North America and beyond, present us with several exciting opportunities at different stages of the process.

 

PROJECT ATLAS

Project Atlas, a key driver of future growth and cost efficiencies, has continued to progress in the period. We are currently in a phased roll-out to our highest revenue trading subsidiary, TR Fastenings (UK), which is expected to complete by the end of calendar year 2022.

 

OUTLOOK

The Board believes that the fundamentals of our business model and strategy position us well to become a bigger, more profitable company in the medium-term. A continued focus on service levels and responsiveness have strengthened the Group's position in its established markets during this challenging period. We continue to see exciting opportunities in high growth and emerging technologies, including in the electric vehicle space, where our secured order pipeline has never been stronger. Strong momentum in contract wins, and new order pipeline, means we are looking ahead with confidence, although we remain mindful of the current macro level headwinds.

 

 

 

Further enquiries please contact:

Trifast plc

Jonathan Shearman, Non-Executive Chair

Mark Belton, Chief Executive Officer

Clare Foster, Chief Financial Officer

Tel: +44 (0) 1825 747630

Email: corporate.enquiries@trifast.com

 

Peel Hunt LLP (Stockbroker & financial adviser)

Mike Bell

Tel: +44 (0) 20 7418 8900

 

TooleyStreet Communications, (IR & media relations)

Fiona Tooley

Tel: +44 (0)7785 703523

Email: fiona@tooleystreet.com

 

 

Editors' notes

About Trifast plc

Trifast (TR) is a leading international specialist in the design, engineering, manufacture, and distribution of high-quality industrial fastenings and Category 'C' components principally to major global assembly industries.

 

TR supplies to c. 5,000 customers in c.75 countries across a wide range of industries, including Light vehicle, Heavy vehicle, Health & Home, Energy, Tech and Infrastructure (ET&I), General industrial and Distributors. As a full-service provider to multinational OEMs and Tier 1 companies spanning several sectors, TR delivers comprehensive support to its customers from concept design through to technical engineering consultancy, manufacturing, supply management and global logistics.

 

TR employs c.1,300 people across 34 business locations within the UK, Asia, Europe, and the USA including seven high-volume, high-quality, and cost-effective manufacturing sites and three technical & innovation centres across the world.

 

For more information, visit

Investor website: www.trifast.com

Commercial website: www.trfastenings.com

LinkedIn: www.linkedin.com/company/tr-fastenings

Twitter: www.twitter.com/trfastenings

Facebook: www.facebook.com/trfastenings

 

Note

Trifast, TR and TR Fastenings are registered trademarks of the Company.

 

LEI number: 213800WFIVE6RUK3CR22

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBKQBQOBKDNPK
Date   Source Headline
25th Apr 20247:00 amRNSTrading update & Notice of Annual results
15th Apr 20242:11 pmRNSDirector/PDMR Shareholding
15th Apr 20241:07 pmRNSDirector/PDMR Shareholding
4th Apr 202410:40 amRNSBlock listing Interim Review
21st Mar 20247:00 amRNSDirector/PDMR Shareholding - Purchase of shares
13th Mar 20242:30 pmRNSDirector/PDMR Shareholding
11th Mar 20247:00 amRNSAppointment & retirement of non-executive director
22nd Feb 20247:00 amRNSDirectorate Change
9th Feb 20247:00 amRNSHolding(s) in Company
1st Feb 202410:09 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSTotal Voting Rights
31st Jan 20249:33 amRNSHolding(s) in Company
24th Jan 20247:00 amRNSDirector/PDMR Shareholding
23rd Jan 202411:23 amRNSDirector/PDMR Shareholding
22nd Jan 20243:20 pmRNSDirector/PDMR Shareholding
22nd Jan 20247:00 amRNSTrading Update
3rd Jan 20245:50 pmRNSTotal Voting Rights
21st Dec 20234:24 pmRNSHolding(s) in Company
21st Dec 20234:18 pmRNSHolding(s) in Company
15th Dec 20237:00 amRNSNon executive director retirement update
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSPDMR - Performance conditions for LTIP award
24th Nov 20232:34 pmRNSDirector/PDMR shareholding - Purchase of shares
21st Nov 20237:00 amRNSHalf-year Report - six months to 30 September 2023
24th Oct 20237:00 amRNSHalf year trading update and notice of results
19th Oct 20237:00 amRNSNon-executive Director appointment
12th Oct 20237:00 amRNSDirectorate retirement
3rd Oct 20234:16 pmRNSBlock listing Interim Review
25th Sep 20233:49 pmRNSHolding(s) in Company
19th Sep 20234:45 pmRNSPDMR Save As You Earn Plan grant of Option
15th Sep 20233:05 pmRNSResult of AGM
15th Sep 20239:15 amRNSCEO appointment
14th Sep 20234:48 pmRNSDirectorate Change
29th Aug 20237:00 amRNSHolding(s) in Company
10th Aug 20237:00 amRNSBoard Appointment
3rd Aug 202311:36 amRNSDirector/PDMR Shareholding
19th Jul 20232:31 pmRNSHolding(s) in Company
19th Jul 20237:00 amRNSAR posting - AGM - Sustainability report & TVR
17th Jul 20231:25 pmRNSHolding(s) in Company
11th Jul 20237:00 amRNSAnnual results - 31 March 2023 - Annual Report
9th Jun 20237:00 amRNSNotice of Annual Results
10th May 202311:38 amRNSHolding(s) in Company
4th May 20233:50 pmRNSDirector Declaration
26th Apr 20237:00 amRNSTrading update
4th Apr 20234:45 pmRNSTotal Voting Rights
4th Apr 20234:43 pmRNSBlock listing Interim Review
29th Mar 20234:47 pmRNSHolding(s) in Company
28th Feb 20236:16 pmRNSPDMR Shareholding
28th Feb 20231:38 pmRNSDirector/PDMR Shareholdings
27th Feb 20233:14 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.